Shawn Kwatra, MD

home / authors / shawn-kwatra-md

Director

John’s Hopkins School of Medicine Itch Center

Baltimore, Maryland

Articles

Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis

Kaitlyn Bader, Assistant Managing Editor;Shawn Kwatra, MD

October 26th 2024

Shawn Kwatra, MD, reviews key highlights of his sessions at Fall Clinical 2024 on the latest updates in itch conditions.

Late-Breaking Data: Povorcitinib Significantly Improves Itch and Lesions in Prurigo Nodularis

Kaitlyn Bader, Senior Editor ;Shawn Kwatra, MD

March 12th 2024

Shawn Kwatra, MD, shares positive updates on phase 2 oral povorcitinib for prurigo nodularis at AAD 2024.

Late-Breaking Data: Long-Term Safety and Efficacy of Largest Prurigo Nodularis Study Ever Conducted

Kaitlyn Bader, Senior Editor ;Shawn Kwatra, MD

March 11th 2024

Shawn Kwatra, MD, presented late-breaking data at AAD 2024 on the largest prurigo nodularis and nemolizumab clinical trial, OLYMPIA.

First US Consensus Published on Uniform Nomenclature and Diagnosis for Neuropathic Pruritus

Kaitlyn Bader, Senior Editor ;Shawn Kwatra, MD

February 21st 2024

Shawn Kwatra, MD, shares insights into neuropathic pruritus’ debilitating effects on patients and how clinicians can use unified nomenclature.

Case 2: Male, 33 Years Old

Shawn Kwatra, MD

January 17th 2024

An expert in dermatology reviews the case of a 33-year-old male patient suffering from atopic dermatitis for the past 3 years. He breaks down the panel's conversation on the use of non-steroidal topicals and emphasizes how patient assistance programs can ease burden for patients and providers.

Case 1: 73-Year-Old African American Female

Shawn Kwatra, MD

January 17th 2024

Shawn Kwatra, MD, presents a case involving a 73-year-old African American female seeking treatment for her atopic dermatitis. In this segment Dr Kwatra explains the panels thoughts and rationale behind the prescribed treatments, discussing how each option works and its limitations.

Shawn Kwatra, MD, Shares Highlights From the 12th World Congress on Itch

Kaitlyn Bader, Senior Editor ;Shawn Kwatra, MD

November 17th 2023

Kwatra presented on the unmet need for itch improvement in patients with skin of color.

Nemolizumab Significantly Reduces Itch and Improves DLQI in Patients With Prurigo Nodularis

Kaitlyn Bader, Senior Editor ;Shawn Kwatra, MD

November 10th 2023

Shawn Kwatra, MD, shares his thoughts on the positive phase 3 data of OLYMPIA 2.

Shawn Kwatra, MD: Nemolizumab Modulates Neuroimmune and Epithelial Dysregulation in Patients with Prurigo Nodularis

Kaitlyn Bader, Senior Editor ;Shawn Kwatra, MD

November 8th 2023

Kwatra discussed his research team’s findings published in JAMA Dermatology.

Shawn Kwatra, MD: Managing Prurigo Nodularis With Biologics

Kaitlyn Bader, Senior Editor ;Shawn Kwatra, MD

October 20th 2023

Kwatra reviewed skin lesions in PN and important treatment considerations for patients at Fall Clinical.

Shawn Kwatra, MD, Reviews Late-Breaking Data of Abrocitinib for Prurigo Nodularis and Chronic Pruritus of Unknown Origin

Kaitlyn Bader, Senior Editor ;Shawn Kwatra, MD

October 17th 2023

Kwatra presented the abrocitinib data at EADV 2023.

Confronting Racial Disparities in Dermatologic Education

Kaitlyn Bader, Senior Editor ;Christopher G. Bunick, MD, PhD;Shawn Kwatra, MD

September 13th 2023

To further discuss the changing landscape of skin of color representation in dermatology, Christopher Bunick, MD, PhD, and Shawn Kwatra, MD, review how they have seen representation change in their own experiences.